Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-05-20, Stock:LLY, The news for the past five days is as follows:
2019-05-13: NEWS1: Lilly's CYRAMZA® (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma.
2019-05-14: NEWS1: Top Research Reports for Alphabet, Eli Lilly & CVS Health.NEWS2: Top Research Reports for Alphabet, Eli Lilly & CVS Health.NEWS3: Top Research Reports for Alphabet, Eli Lilly & CVS Health.NEWS4: Lilly's Cyramza Gets FDA Nod for Second-Line Liver Cancer.NEWS5: Lilly's Cyramza Gets FDA Nod for Second-Line Liver Cancer.NEWS6: Lilly's Cyramza Gets FDA Nod for Second-Line Liver Cancer.
2019-05-15: NEWS1: Data Presentations at ASCO 2019 Highlight Lilly's Targeted Approach to Developing Treatments for Patients Living with Cancer.NEWS2: 3 Stocks With Big News Coming at ASCO 2019.NEWS3: 3 Stocks With Big News Coming at ASCO 2019.NEWS4: The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, CVS, Marriott and TELUS.NEWS5: The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, CVS, Marriott and TELUS.NEWS6: 3 Top Diabetes Stocks to Watch in May.NEWS7: 3 Top Diabetes Stocks to Watch in May.NEWS8: 3 Stocks With Big News Coming at ASCO 2019.NEWS9: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 16, 2019.NEWS10: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 16, 2019.NEWS11: The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, CVS, Marriott and TELUS.NEWS12: 3 Top Diabetes Stocks to Watch in May.NEWS13: Lilly to Participate in Bank of America Merrill Lynch Health Care Conference.
2019-05-16: NEWS1: Lilly to Participate in UBS Global Healthcare Conference.NEWS2: Pfizer's Eczema Candidate Meets All Goals in Phase III Study.NEWS3: Pfizer's Eczema Candidate Meets All Goals in Phase III Study.NEWS4: Pfizer's Eczema Candidate Meets All Goals in Phase III Study.
2019-05-17: NEWS1: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.NEWS2: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.NEWS3: Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs.

Answer: Rise